EMEA-001329-PIP02-13

Key facts

Active substance
Expanded autologous bone marrow-derived osteoblastic cells
Therapeutic area
Other
Decision number
P/0164/2014
PIP number
EMEA-001329-PIP02-13
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Treatment of non-traumatic osteonecrosis
Route(s) of administration
Intraosseous use
Contact for public enquiries
Bone Therapeutics S.A.
Belgium
E-mail: preob.pip@bonetherapeutics.com
Tel. + 32 25295990
Fax +32 25295993
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating